162 related articles for article (PubMed ID: 1938513)
1. The impact of pelvic recurrence and elective pelvic irradiation on survival and treatment morbidity in early-stage Hodgkin's disease.
Mendenhall NP; Taylor BW; Marcus RB; Million RR
Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1157-65. PubMed ID: 1938513
[TBL] [Abstract][Full Text] [Related]
2. Pelvic relapse following subtotal lymphoid irradiation in early stage Hodgkin's disease--an analysis of risk, management, and outcome.
Tate DJ; Hoppe RT
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1239-44. PubMed ID: 7607947
[TBL] [Abstract][Full Text] [Related]
3. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital.
Shah AB; Hudson MM; Poquette CA; Luo X; Wilimas JA; Kun LE
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):867-77. PubMed ID: 10386644
[TBL] [Abstract][Full Text] [Related]
5. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience.
Barton M; Boyages J; Crennan E; Davis S; Fisher RJ; Hook C; Johnson N; Joseph D; Khoo V; Liew KH; Morgan G; O'Brien P; Pendlebury S; Pratt G; Quong G; Roos DE; Thornton D; Trotter G; Walker Q; Wallington M
Radiother Oncol; 1996 Apr; 39(1):1-7. PubMed ID: 8735487
[TBL] [Abstract][Full Text] [Related]
7. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
8. Cure of early-stage Hodgkin's disease with subtotal nodal irradiation.
Wasserman TH; Trenkner DA; Fineberg B; Kucik N
Cancer; 1991 Sep; 68(6):1208-15. PubMed ID: 1873772
[TBL] [Abstract][Full Text] [Related]
9. Are pelvic irradiation and routine staging laparotomy necessary in clinically staged IA and IIA Hodgkin's disease?
Griffin T; Gerdes A; Parker R; Taylor E; Hafermann M; Taylor W; Tesh D
Cancer; 1977 Dec; 40(6):2914-6. PubMed ID: 412583
[TBL] [Abstract][Full Text] [Related]
10. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
Liao Z; Ha CS; Fuller LM; Hagemeister FB; Cabanillas F; Tucker SL; Hess MA; Cox JD
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1047-56. PubMed ID: 9719114
[TBL] [Abstract][Full Text] [Related]
11. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
[TBL] [Abstract][Full Text] [Related]
13. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
Carde P; Hayat M; Cosset JM; Somers R; Burgers JM; Sizoo W; Meerwaldt JH; Hagenbeek A; Monconduit M; van der Schueren E
NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775
[TBL] [Abstract][Full Text] [Related]
14. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
15. Liver irradiation in stage IIIA Hodgkin's disease patients with splenic involvement.
Lee CK; Bloomfield CD; Levitt SH
Am J Clin Oncol; 1984 Apr; 7(2):149-57. PubMed ID: 6702719
[TBL] [Abstract][Full Text] [Related]
16. The treatment of stage IIIA Hodgkin's disease.
Lister TA; Dorreen MS; Faux M; Jones AE; Wrigley PF
J Clin Oncol; 1983 Dec; 1(12):745-9. PubMed ID: 6689424
[TBL] [Abstract][Full Text] [Related]
17. Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.
Carde P; Burgers JM; Henry-Amar M; Hayat M; Sizoo W; Van der Schueren E; Monconduit M; Noordijk EM; Lustman-Marechal J; Tanguy A
J Clin Oncol; 1988 Feb; 6(2):239-52. PubMed ID: 2578012
[TBL] [Abstract][Full Text] [Related]
18. Subdiaphragmatic Hodgkin's disease: the University of Florida experience.
Hull MC; Mendenhall NP; Colgan ME
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):161-6. PubMed ID: 11777634
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
Vlachaki MT; Hagemeister FB; Fuller LM; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):593-9. PubMed ID: 9231684
[TBL] [Abstract][Full Text] [Related]
20. Treatment of patients with "minimal" stage IIIA Hodgkin's disease.
Powlis WD; Mauch P; Goffman T; Goodman RL
Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1437-42. PubMed ID: 3305442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
